🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the following randomized open label trial is to de...
Status
Terminated
Location
Universitary hospital of Lyon
Start Date
2014-06
Trial ID
NCT02056938
Treatments Being Tested
The purpose of this study was to compare the safety and efficacy of three i...
Status
Completed
Location
Novartis
Start Date
2005-10
Trial ID
NCT00251004
Treatments Being Tested
This study is designed to evaluate efficacity and safety of everolimus or (...
Status
Completed
Location
CHU Amiens
Start Date
2009-03
Trial ID
NCT01028092
Treatments Being Tested
This study is designed to evaluate whether tacrolimus dose reduction in de ...
Status
Completed
Location
Novartis
Start Date
2006-06
Trial ID
NCT00369161
Treatments Being Tested
To demonstrate that cyclosporine-sparing immunosuppressions with the standa...
Status
Completed
Location
Multiple Locations
Start Date
2011-06
Trial ID
NCT01817322
The primary objective of the trial is to evaluate efficacy and safety of de...
Status
Unknown
Location
Regensburg University Hospital
Start Date
2011-06
Trial ID
NCT01023542
Treatments Being Tested
The primary purpose of this study is to demonstrate the safety of allogenei...
Status
Completed
Location
University of Illinois at Chicago
Start Date
2004-11
Trial ID
NCT00566813
Treatments Being Tested
IgA nephropathy (IgAN) is a histologically defined glomerulonephritis (rena...
Status
Terminated
Location
CHU de BESANCON
Start Date
2011-01-08
Trial ID
NCT02523768
This a pilot, explorative study to define the safety and biological/mechani...
Status
Terminated
Location
Nephrology Unit
Start Date
2008-05
Trial ID
NCT00752479
The aims of this study are to extensively study the levels of CD25-Receptor...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-03
Trial ID
NCT01596062
Treatments Being Tested